Intel secures up to $20 billion to support its foundry initiative in competition with TSMC.

      Intel has revealed a common-stock offering worth $15 billion, which could expand to $20 billion if underwriters take their overallotment options. This is a bold strategy for a company that recently seemed like a cautionary example, highlighting the significant turnaround in the chipmaker’s fortunes over the past year.

      The timing is strategic. Intel's shares have almost tripled in 2026, outperforming AMD, Nvidia, and the Philadelphia Semiconductor Index, which has risen by roughly 75% during the same period. When a stock is performing so well, issuing new shares is one of the most cost-effective ways to raise capital, and Intel is clearly taking advantage of this favorable situation.

      The offering was priced at approximately $95 per share or higher, representing a slight discount of around 2.6% from Monday’s closing price of $97.52. This minimal concession, by the standards of large equity offerings, demonstrates the strong interest investors have in a company that many had dismissed during its restructuring challenges.

      The funds raised will be dedicated to the most critical aspect of Intel’s revitalization. The money will support its foundry division, financing new manufacturing facilities and advanced packaging as the company aims to compete with TSMC in the capital-intensive business of making chips for other firms. As demand has increased, this ambition has become costlier. Orders for AI-driven processors have exceeded Intel’s current capabilities, prompting the company to raise its 2026 capital expenditure forecast from $18 billion to $20 billion and to commit to production using its advanced 14A process by 2028. New equity will help fund these initiatives without accumulating additional debt.

      There is real momentum behind this initiative as well. Intel has announced Tesla as a customer for its 14A process, and reports suggest a potential partnership with Apple, both of which would enhance the credibility of a foundry that has long struggled to attract major clients away from its Taiwanese competitor.

      Investors appear enthusiastic, with demand for the offering reportedly surpassing $100 billion, a remarkable statistic that illustrates the significant shift in sentiment. One analyst succinctly stated that raising funds “makes perfect sense” following a nearly five-fold increase in the stock since last August.

      This transformation did not occur in isolation. It has been supported by the U.S. government’s investment in Intel, numerous high-profile investments, and strategic moves such as partnering with Musk’s Terafab and committing billions to production in Ireland.

      However, the market reaction on the day of the announcement served as a useful reality check. Intel's shares fell about 4 to 5% following the news of the sale, reflecting dilution rather than a loss of confidence. The increase in outstanding shares means that each existing shareholder now holds a somewhat smaller portion of the company, causing the stock price to adjust accordingly.

      The deeper question remains whether the foundry strategy will be successful. Competing with TSMC poses a significant challenge, one that has previously caused Intel difficulties, and the 14A roadmap is still unproven at the volumes and yields necessary for commercial viability. Securing Tesla as a customer and pursuing a partnership with Apple are positive developments, but they do not guarantee enduring, profitable contract manufacturing.

      In addition, Intel is continuing to develop the products associated with that manufacturing, from its 18A process and new chips to the packaging technologies it aims to use for differentiation. The sale of shares provides time and capacity for these efforts, but ultimately, execution—not just funding—will be the key factor that determines the outcome.

      For the moment, Intel is doing precisely what a recovering company should do when presented with an opportunity. It is transforming an impressive rally into the necessary funding for its most critical and uncertain gamble, hoping that the goodwill it has generated will endure long enough to prove skeptics wrong.